![]() |
市場調查報告書
商品編碼
1830972
髖關節植入物市場Hip Implants Market |
髖關節植入物市場預計將從 2024 年的 73.7 億美元擴大到 2031 年的 98 億美元,預計 2024 年至 2031 年的複合年成長率為 4.1%。
市場洞察與分析師觀點:髖關節植入物市場正經歷快速成長,這得益於髖關節手術、髖關節損傷、骨關節炎和類風濕性關節炎病例的增加。此外,企業為保持競爭力而採取的策略性措施也推動著市場成長。例如,2023年8月,全錄輝(Smith & Nephew)在印度推出了初次和翻修髖關節置換術的OR3O雙動系統。 OR3O採用全錄輝先進的承載面OXINIUM DH,該系統採用襯墊和專有的OXINIUM on XLPE,無需模組化鈷鉻襯墊和/或鈷鉻頭球,從而降低了與合金相關的磨損和腐蝕風險。因此,旨在滿足客戶需求的創新技術顯著成長,預計將為髖關節植入物市場預測帶來新的趨勢。
成長動力與挑戰:根據骨關節炎行動聯盟報告,骨關節炎是美國最常見的關節炎之一,影響近 3,250 萬人,其中 43% 的人口在 2020 年年齡超過 65 歲。根據疾病管制與預防中心的數據,2020 年約有 23% 的美國人口患有關節炎。此外,加拿大關節炎研究中心估計,超過 600 萬加拿大人患有骨關節炎,預計到 2040 年將上升到 1,050 萬人。骨關節炎可導致髖部損傷和骨折,因為關節炎患者的骨密度通常低於非關節炎患者。
世界衛生組織 (WHO) 估計,2019 年全球 60 歲以上人口達 10 億,預計到 2030 年將達到 14 億,到 2050 年將達到 21 億。預計在此期間,老年人口比例將從約 15% 增加到 24% 左右。歐盟統計局也報告稱,2021 年歐洲 60 歲以上人口比例最高(20.8%)。此外,到 2050 年,除非洲外,所有地區 60 歲以上人口比例將超過 25%。因此,老年人口的成長導致各種骨科疾病的增加,例如髖部損傷、骨關節炎以及因跌倒和其他不幸事件導致的髖關節脫位,從而推動了髖關節植入物市場的成長。
策略洞察報告細分和範圍:髖關節植入物市場按產品類型、材料、最終用戶和地理分類。根據產品類型,市場分為全置換、部分置換、髖關節表面置換和髖關節翻修植入物。依材料,市場包括金屬對聚乙烯、陶瓷對陶瓷、陶瓷對金屬、陶瓷對聚乙烯等。按最終用戶,市場細分為醫院、骨科診所、門診手術中心等。從地域來看,市場分為北美(美國、加拿大和墨西哥)、歐洲(英國、德國、法國、義大利、西班牙、俄羅斯和歐洲其他地區)、亞太地區(中國、日本、印度、韓國、澳洲和亞太其他地區)、中東和非洲(阿拉伯聯合大公國、沙烏地阿拉伯、南非和中東和非洲其他地區)以及南美洲和中美洲(巴西、阿根廷和南美洲其他地區)。
細分分析:依產品類型對髖關節植入物市場進行分析,包括股骨重建、髖臼重建、髖關節表面置換、髖關節翻修植入物、軸承和多孔金屬技術以及全置換植入物。 2022年,全置換植入物細分市場佔據髖關節植入物市場的最大佔有率,預計在2022年至2030年期間達到最高複合年成長率。
依材料分類,市場可分為金屬-聚乙烯、陶瓷-陶瓷、陶瓷-金屬和陶瓷-聚乙烯。 2022年,金屬-塑膠髖關節植入物佔據最大市場佔有率,預計在2022年至2030年期間的髖關節植入物市場中,其複合年成長率最高。該領域的成長得益於精準的療效、耐用性和成本效益等優勢。此外,併發症更少、技術進步和磨損顆粒減少等優勢也推動了金屬-塑膠髖關節植入物的需求。
按最終用戶分類,市場可細分為醫院、骨科診所、門診手術中心及其他。 2022年,醫院市場佔據最大市場佔有率,預計2022年至2030年期間的複合年成長率最高。醫院髖關節植入手術數量的不斷增加,正在推動全球該領域的成長。醫院工作人員訓練有素,熟悉手術期間或術後可能出現的併發症,這使其能夠處理緊急情況並提供全面的患者護理。在醫院環境下,手術報銷流程也更方便、更容易管理。此外,全球醫院數量的不斷成長有望在預測期內保持該領域的主導地位,並支持髖關節植入市場的成長。
區域分析:從地理來看,髖關節植入物市場報告分為北美、歐洲、亞太地區、中東和非洲以及南美和中美。北美是全球髖關節植入物市場成長的最大貢獻者。預計在2022年至2030年期間,亞太地區的髖關節植入物市場複合年成長率最高。髖關節植入物、產品發布以及運動相關髖關節損傷的發病率上升是推動美國市場成長的主要因素。根據威科健康公司(Wolters Kluwer Health, Inc.)發表的文章《髖關節骨折護理與國家系統》,美國每年約有25萬至30萬人因髖關節骨折住院。據估計,到2040年,約有50萬人將因髖關節骨折而就醫。美國骨科醫師學會指出,65歲及以上的人尤其容易因家庭或社區環境中的跌倒而發生髖關節骨折。根據美國國家醫學圖書館發表的《髖關節概述》一文,髖部骨折後第一年患者花費約4萬美元,美國髖部骨折治療總費用每年高達近170億美元。因此,美國髖部骨折和損傷的發生率不斷上升,以及治療費用的上漲,是目前美國髖部植入物市場的趨勢。
髖關節植入物市場報告範圍行業發展和未來機會:髖關節植入物市場的主要參與者已經概述了各種策略,包括:
2022年8月,Exatech推出了全新的全髖關節置換系統,以Spartan柄和Logical杯為特色。 Spartan髖關節柄滿足了當代患者的需求,並融合了最新的外科手術進展。 Logical杯是一款模組化髖臼系統,專為活動量大的患者設計,可提高醫院和門診手術中心的手術效率。 2022年9月,全錄輝(Smith & Nephew)在日本推出了初次和翻修髖關節置換術的OR3O雙動系統。這種先進的承載表面OXINIUM DH用於其線性和專有的OXINIUM on XLPE聚乙烯插入件和股骨頭。競爭格局和主要公司:髖關節植入物市場報告中提到的一些領先公司包括全錄輝、Exactech、Zimmer Biomet、Stryker Corporation、DJO Surgical (Enovis)、Medacta、Conformis、DePuy Orthopaedics、MicroPort Ortedics和Symbhopedics和Symbios。這些公司專注於地理擴張和新產品發布,以滿足日益成長的全球消費者需求,並增強其特色產品組合。其國際影響力使其能夠滿足廣泛的客戶群,促進市場成長。
The hip implants market is projected to expand from US$ 7.37 billion in 2024 to US$ 9.80 billion by 2031, with an expected CAGR of 4.1% from 2024 to 2031.
Market Insights and Analyst Perspective:The hip implants market is experiencing rapid growth driven by an increase in hip surgeries, hip injuries, osteoarthritis, and rheumatoid arthritis. Additionally, strategic initiatives by companies to maintain competitiveness are propelling market growth. For example, in August 2023, Smith & Nephew introduced the OR3O Dual Mobility System in India for primary and revision hip arthroplasty. The OR3O features Smith & Nephew's advanced bearing surface, OXINIUM DH, which utilizes a liner and proprietary OXINIUM on XLPE, eliminating the need for a modular CoCr liner and/or CoCr head ball, thereby reducing wear and corrosion risks associated with the alloy. Consequently, a notable increase in innovative technologies aimed at meeting customer needs is expected to introduce new trends in the hip implants market forecast.
Growth Drivers and Challenges:As reported by the Osteoarthritis Action Alliance, osteoarthritis is one of the most prevalent forms of arthritis in the US, affecting nearly 32.5 million individuals, with 43% of this population being over 65 years old in 2020. According to the Centers for Disease Control and Prevention, approximately 23% of the US population had arthritis in 2020. Furthermore, Arthritis Research Canada estimates that over 6 million Canadians suffer from osteoarthritis, a figure projected to rise to 10.5 million by 2040. Osteoarthritis can lead to hip injuries and fractures, as patients with arthritis typically have lower bone density compared to those without the condition.
The World Health Organization (WHO) estimated that in 2019, there were 1 billion individuals aged over 60, a number expected to reach 1.4 billion by 2030 and 2.1 billion by 2050. The share of the geriatric population is anticipated to increase from approximately 15% to around 24% during this timeframe. Eurostat also reported that Europe had the highest percentage (20.8%) of individuals aged over 60 in 2021. Moreover, by 2050, all regions except Africa will have more than 25% of their populations aged over 60. Thus, the rise in the elderly population has led to an increase in various orthopedic conditions, such as hip injuries, osteoarthritis, and hip dislocations due to falls and other unfortunate events, contributing to the growth of the hip implants market.
Strategic Insights
Report Segmentation and Scope:The hip implants market is categorized by product type, material, end user, and geography. By product type, the market is divided into total replacement, partial replacement, hip resurfacing, and revision hip implants. By material, the market includes metal-on-polyethylene, ceramic-on-ceramic, ceramic-on-metal, ceramic-on-polyethylene, and others. By end user, the market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers, and others. Geographically, the market is divided into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Segmental Analysis:The analysis of the hip implants market by product type includes femoral reconstruction, acetabular reconstruction, hip resurfacing, revision hip implants, bearing and porous metal technologies, and total replacement implants. In 2022, the total replacement implants segment held the largest share of the hip implants market and is expected to achieve the highest CAGR from 2022 to 2030.
By material, the market is categorized into metal-on-polyethylene, ceramic-on-ceramic, ceramic-on-metal, and ceramic-on-polyethylene. In 2022, the metal-on-plastic segment held the largest market share and is projected to experience the highest CAGR in the hip implants market forecast from 2022 to 2030. This segment's growth is driven by advantages such as precise outcomes, durability, and cost-effectiveness. Additionally, benefits like fewer complications, technological advancements, and reduced wear particles are boosting the demand for metal-on-plastic hip implants.
By end user, the market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers, and others. In 2022, the hospital segment held the largest market share and is expected to record the highest CAGR from 2022 to 2030. The increasing number of hip implant surgeries in hospitals is driving growth in this segment globally. Hospital staff are well-trained and knowledgeable about potential complications during or after surgery, enabling them to manage emergencies and provide comprehensive patient care. Reimbursement processes for surgeries are also more accessible and manageable within hospital settings. Furthermore, the growing number of hospitals worldwide is likely to maintain the segment's dominance and support the growth of the hip implants market during the forecast period.
Regional Analysis:Geographically, the hip implants market report is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the global hip implants market growth. The Asia Pacific region is expected to exhibit the highest CAGR in the hip implants market forecast from 2022 to 2030. The rising incidence of hip implants, product launches, and sports-related hip injuries are primarily driving market growth in the US. According to the article "Hip Fracture Care and National Systems" published by Wolters Kluwer Health, Inc., approximately 250,000 to 300,000 individuals in the US are hospitalized for hip fractures each year. It is estimated that by 2040, around 500,000 people will seek medical attention for hip fractures. The American Academy of Orthopaedic Surgeons notes that individuals aged 65 and older are particularly susceptible to hip fractures due to falls in household or community settings. According to the article "Hip Overview" published in the National Library of Medicine, patients spend about US$ 40,000 in the first year following a hip fracture, with the total cost of hip fracture care in the US reaching nearly US$ 17 billion annually. Therefore, the increasing prevalence of hip fractures and injuries in the US, along with rising treatment costs, are current trends in the hip implants market in the US.
Hip Implants Market Report Scope
Industry Developments and Future Opportunities:Key players in the Hip Implants Market have outlined various strategies, including:
In August 2022, Exatech launched a new total hip arthroplasty system featuring the Spartan Stem and Logical Cup. The Spartan Hip Stem addresses contemporary patient needs and incorporates the latest surgical advancements. The Logical Cup is a modular acetabular system designed for highly active patients while facilitating efficient surgical processes in hospitals and ambulatory surgical centers.
In September 2022, Smith & Nephew introduced the OR3O Dual Mobility System for primary and revision hip arthroplasty in Japan. This advanced bearing surface, OXINIUM DH, is utilized for its linear and proprietary OXINIUM on XLPE for polyethylene inserts and femoral heads.
Competitive Landscape and Key Companies:Some of the leading companies featured in the hip implants market report include Smith & Nephew, Exactech, Zimmer Biomet, Stryker Corporation, DJO Surgical (Enovis), Medacta, Conformis, DePuy Orthopaedics, MicroPort Orthopedics, and Symbios. These companies are focusing on geographic expansion and new product launches to meet the increasing global consumer demand and enhance their specialty product portfolios. Their international presence enables them to cater to a broad customer base, facilitating market growth.